Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Turner

Showing results (81-90 of 295) with videos related to

Pageof 30
Sort By:
Plos One|January 7, 2014
Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosisTomer Fekete, Neta Zach, Lilianne R Mujica-Parodi, et al.
Molecular Neurobiology|February 21, 2018
Towards a TDP-43-Based Biomarker for ALS and FTLDEmily Feneberg, Elizabeth Gray, Olaf Ansorge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 25, 2015
Mind the gap: the mismatch between clinical and imaging metrics in ALSEsther Verstraete, Martin R Turner, Julian Grosskreutz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Premorbid brain structure influences risk of amyotrophic lateral sclerosisAlexander G Thompson, Bernd Taschler, Stephen M Smith, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral SclerosisDavid G Lester, Kevin Talbot, Martin R Turner, et al.
The Lancet. Neurology|December 17, 2008
Biomarkers in amyotrophic lateral sclerosisMartin R Turner, Matthew C Kiernan, P Nigel Leigh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2017
Kinnier Wilson's puzzling features of amyotrophic lateral sclerosisMartin R Turner, Andrew Eisen, Matthew C Kiernan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2016
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onsetMalcolm Proudfoot, Ashley Jones, Kevin Talbot, et al.
Journal of Neurology|July 29, 2018
Amyotrophic lateral sclerosis: the complex path to precision medicineKevin Talbot, Emily Feneberg, Jakub Scaber, et al.
Pageof 30

Showing results (81-90 of 295) with videos related to

Sort By:
Pageof 30
Plos One|January 7, 2014
Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosisTomer Fekete, Neta Zach, Lilianne R Mujica-Parodi, et al.
Molecular Neurobiology|February 21, 2018
Towards a TDP-43-Based Biomarker for ALS and FTLDEmily Feneberg, Elizabeth Gray, Olaf Ansorge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 25, 2015
Mind the gap: the mismatch between clinical and imaging metrics in ALSEsther Verstraete, Martin R Turner, Julian Grosskreutz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Premorbid brain structure influences risk of amyotrophic lateral sclerosisAlexander G Thompson, Bernd Taschler, Stephen M Smith, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral SclerosisDavid G Lester, Kevin Talbot, Martin R Turner, et al.
The Lancet. Neurology|December 17, 2008
Biomarkers in amyotrophic lateral sclerosisMartin R Turner, Matthew C Kiernan, P Nigel Leigh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2025
Progression and life expectancy in primary lateral sclerosisDavid G Lester, Alexander G Thompson, Kevin Talbot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2017
Kinnier Wilson's puzzling features of amyotrophic lateral sclerosisMartin R Turner, Andrew Eisen, Matthew C Kiernan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2016
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onsetMalcolm Proudfoot, Ashley Jones, Kevin Talbot, et al.
Journal of Neurology|July 29, 2018
Amyotrophic lateral sclerosis: the complex path to precision medicineKevin Talbot, Emily Feneberg, Jakub Scaber, et al.
Pageof 30